N/A N=20 Randomized Treatment

Transcranial Magnetic Stimulation (TMS) for CRPS

Complex Regional Pain Syndrome (CRPS)

Bottom Line

View on ClinicalTrials.gov: NCT02067273 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

May 2017

Primary outcome: Primary: Present Pain Intensity — 6.5; 6.3; 3.1; 3.7 Units on a scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Transcranial Magnetic Stimulation (TMS) (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Stanford University
Primary completion: Feb 2015

Outcome Measures

Outcome	Result	p-value
PRIMARY Present Pain Intensity	6.5; 6.3; 3.1; 3.7; 4.6; 4.3	—

Summary

The purpose of this pilot study is to test the durability of response to Transcranial Magnetic Stimulation (TMS) for the symptoms of Complex Regional Pain Syndrome (CRPS). The investigators will test various methods of TMS for varying lengths of time in a pilot study to investigate what the clinical impact.

Eligibility Criteria

Inclusion Criteria

Age 18 or older
Diagnosis of CRPS (complex regional pain syndrome)
Average pain level reported on Numerical Rating Scale meets entry criteria
Ability to perform the experimental task and procedures.

Exclusion Criteria

MRI contraindication (metal implants or devices, claustrophobia)
TMS Contraindication (eg metal implant or devices near the site of stimulation)
History of epilepsy
History of a psychological or psychiatric disorder that would interfere with study procedures, at the discretion of the researcher.
Neurologic illness that would interfere with brain integrity
Current medical condition or medication use that would interfere with study procedures or data integrity, at the discretion of the researcher.
Currently pregnant or planning to become pregnant.
On going legal action or disability claim.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02067273). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.